Paper36135
Methotrexate, a high-affinity pseudosubstrate of dihydrofolate reductase.
Williams JW and 2 others. Biochemistry, 1979. Cited by 226 papers, by iCite.
Cite this record
ConductScience Library. Methotrexate, a high-affinity pseudosubstrate of dihydrofolate reductase. Papers, record 36135. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36135
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Methotrexate | Major topic |
| Streptococcus | Major topic |
| Tetrahydrofolate Dehydrogenase | Major topic |
| Kinetics | |
| Mathematics | |
| NADP | |
| Oxidation-Reduction | |
| Protein Binding |
Source PubMed
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 226 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41959532 | Microbial metabolism of methotrexate produces a STAT3 signaling molecule that alleviates gut inflammation. | bioRxiv | 2026 | https://conductscience.org/library/papers/41959532 | PubMed |
| 41509643 | A new compound that extends the lifespan of worms, with favorable in vitro properties and a lack of toxicity in rodents. | RSC Med Chem | 2026 | https://conductscience.org/library/papers/41509643 | PubMed |
| 41003927 | Propeptide-mediated enhancement of hyperthermophilic subtilisin-like protease expression in Escherichia coli. | AMB Express | 2025 | https://conductscience.org/library/papers/41003927 | PubMed |
| 37875111 | Methotrexate-based PROTACs as DHFR-specific chemical probes. | Cell Chem Biol | 2024 | https://conductscience.org/library/papers/37875111 | PubMed |
| 37655909 | High selectivity of the hyperthermophilic subtilase propeptide domain toward inhibition of its cognate protease. | Microbiol Spectr | 2023 | https://conductscience.org/library/papers/37655909 | PubMed |
| 36627750 | One-carbon metabolic enzymes are regulated during cell division and make distinct contributions to the metabolome and cell cycle progression in Saccharomyces cerevisiae. | G3 (Bethesda) | 2023 | https://conductscience.org/library/papers/36627750 | PubMed |
| 34660967 | Effects of Distal Mutations on Ligand-Binding Affinity in E. coli Dihydrofolate Reductase. | ACS Omega | 2021 | https://conductscience.org/library/papers/34660967 | PubMed |
| 34104654 | A Role for Folate in Microbiome-Linked Control of Autoimmunity. | J Immunol Res | 2021 | https://conductscience.org/library/papers/34104654 | PubMed |
| 32251371 | Directional conformer exchange in dihydrofolate reductase revealed by single-molecule nanopore recordings. | Nat Chem | 2020 | https://conductscience.org/library/papers/32251371 | PubMed |
| 31303985 | Revitalizing antifolates through understanding mechanisms that govern susceptibility and resistance. | Medchemcomm | 2019 | https://conductscience.org/library/papers/31303985 | PubMed |
| 30192413 | Chemical space of Escherichia coli dihydrofolate reductase inhibitors: New approaches for discovering novel drugs for old bugs. | Med Res Rev | 2019 | https://conductscience.org/library/papers/30192413 | PubMed |
| 28819543 | Diosmin Attenuates Methotrexate-Induced Hepatic, Renal, and Cardiac Injury: A Biochemical and Histopathological Study in Mice. | Oxid Med Cell Longev | 2017 | https://conductscience.org/library/papers/28819543 | PubMed |
| 28525268 | Rational Design of Novel Allosteric Dihydrofolate Reductase Inhibitors Showing Antibacterial Effects on Drug-Resistant Escherichia coli Escape Variants. | ACS Chem Biol | 2017 | https://conductscience.org/library/papers/28525268 | PubMed |
| 28349498 | Halophilic mechanism of the enzymatic function of a moderately halophilic dihydrofolate reductase from Haloarcula japonica strain TR-1. | Extremophiles | 2017 | https://conductscience.org/library/papers/28349498 | PubMed |
| 26414808 | Ligand binding studies, preliminary structure-activity relationship and detailed mechanistic characterization of 1-phenyl-6,6-dimethyl-1,3,5-triazine-2,4-diamine derivatives as inhibitors of Escherichia coli dihydrofolate reductase. | Eur J Med Chem | 2015 | https://conductscience.org/library/papers/26414808 | PubMed |
| 25703118 | Insights into the slow-onset tight-binding inhibition of Escherichia coli dihydrofolate reductase: detailed mechanistic characterization of pyrrolo [3,2-f] quinazoline-1,3-diamine and its derivatives as novel tight-binding inhibitors. | FEBS J | 2015 | https://conductscience.org/library/papers/25703118 | PubMed |
| 24820793 | Protein mass-modulated effects in the catalytic mechanism of dihydrofolate reductase: beyond promoting vibrations. | J Am Chem Soc | 2014 | https://conductscience.org/library/papers/24820793 | PubMed |
| 24347635 | Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/24347635 | PubMed |
| 23155486 | Mechanistic and structural basis for inhibition of thymidylate synthase ThyX. | Open Biol | 2012 | https://conductscience.org/library/papers/23155486 | PubMed |
| 22234658 | Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate. | Photochem Photobiol Sci | 2012 | https://conductscience.org/library/papers/22234658 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36135
GET https://conductscience.org/api/papers/v1/36135/cited_by?page=2